Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

University of Guelph

$14,979.00

Identification of candidate components of a novel Bordetella avium vaccine to prevent turkey coryza

EF 2006-07

Résumé
The bacterium Bordetella avium infects the respiratory tract of turkeys to cause turkey coryza that is mainly characterised by nasal discharge. This disease is often associated with poor weight gain of affected birds. In most cases the bird will clear the infection within two to four weeks. However, an important complication of B. avium infection is damage to the bird's respiratory tract that renders it more susceptible to other secondary infections. Thus, B. avium infection not only leads to turkey coryza but also to an increased incidence of other, more serious infections. Current vaccines to prevent B. avium infection of turkeys do not work well and comprise poorly characterised attenuated strains of the bacterium. Modern vaccinology has progressed well beyond the process of using such poorly understood strains as vaccines. Rational vaccine design, particularly using purified components of bacteria to formulate an acellular vaccine, is a far more successful approach to producing effective vaccines to prevent infection. This project will identify the B. avium components involved in its ability to colonise and damage the turkey respiratory tract as the starting point to developing a novel and effective vaccine to protect turkeys against B. avium infection. Eliminating or significantly decreasing B. avium infections among commercial turkey flocks will help to reduce the burden of disease endured by turkey producers. This industry is an important source of economic activity in Canada and improvements to turkey production processes will result in significant economic benefits to the industry and to Canada.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
321736-2005
Name nom
Prescott, John
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2005
Award amount
14979
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
2
Nb partie
2
Application title
Identification of candidate components of a novel Bordetella avium vaccine to prevent turkey coryza
Keyword
NA
Application summary
The bacterium Bordetella avium infects the respiratory tract of turkeys to cause turkey coryza that is mainly characterised by nasal discharge. This disease is often associated with poor weight gain of affected birds. In most cases the bird will clear the infection within two to four weeks. However, an important complication of B. avium infection is damage to the bird's respiratory tract that renders it more susceptible to other secondary infections. Thus, B. avium infection not only leads to turkey coryza but also to an increased incidence of other, more serious infections. Current vaccines to prevent B. avium infection of turkeys do not work well and comprise poorly characterised attenuated strains of the bacterium. Modern vaccinology has progressed well beyond the process of using such poorly understood strains as vaccines. Rational vaccine design, particularly using purified components of bacteria to formulate an acellular vaccine, is a far more successful approach to producing effective vaccines to prevent infection. This project will identify the B. avium components involved in its ability to colonise and damage the turkey respiratory tract as the starting point to developing a novel and effective vaccine to protect turkeys against B. avium infection. Eliminating or significantly decreasing B. avium infections among commercial turkey flocks will help to reduce the burden of disease endured by turkey producers. This industry is an important source of economic activity in Canada and improvements to turkey production processes will result in significant economic benefits to the industry and to Canada.